+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gluten-Free Malt Extracts - Global Strategic Business Report

  • PDF Icon

    Report

  • 281 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6088925
The global market for Gluten-Free Malt Extracts was valued at US$8.9 Billion in 2025 and is projected to reach US$11.9 Billion by 2032, growing at a CAGR of 4.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Gluten-Free Malt Extracts Market - Key Trends & Drivers Summarized

Why Are Gluten-Free Malt Extracts Gaining Prominence in Specialized Nutrition and Food Manufacturing?

Gluten-free malt extracts are rapidly emerging as a valuable ingredient in the global food and beverage industry, particularly as consumer demand for gluten-free products accelerates. Traditionally derived from barley - a gluten-containing grain - conventional malt extracts are unsuitable for individuals with celiac disease or gluten sensitivity. In response, manufacturers have developed malt extracts from alternative gluten-free sources such as rice, sorghum, millet, and corn. These products offer the same functional and flavor-enhancing qualities as traditional malt - such as color, sweetness, enzymatic activity, and mouthfeel - without triggering adverse reactions in gluten-intolerant populations.

The market’s expansion is closely tied to the broader gluten-free food trend, which is no longer limited to a niche health condition but now reflects a global lifestyle shift toward allergen-free, clean-label, and plant-based eating. As more consumers embrace gluten-free diets for perceived health benefits or as part of broader wellness routines, demand for safe and functional replacements in formulations is rising. Gluten-free malt extracts are increasingly used in bakery, brewing, dairy, snacks, cereals, and confectionery products to deliver authentic taste and color while ensuring compliance with gluten-free labeling standards. This aligns with ongoing reformulation efforts by food manufacturers to meet dietary preferences without compromising sensory appeal.

How Is Ingredient Innovation Supporting the Growth of Gluten-Free Malt Extracts?

Significant innovations in ingredient processing and grain sourcing are driving the development of high-quality gluten-free malt extracts. Food technologists are optimizing enzymatic malting and extraction methods to replicate the functional properties of traditional barley malt using non-gluten grains like rice and sorghum. These processes allow for the production of concentrated syrups and powders that offer similar caramelization potential, fermentation support, and nutritional content. Furthermore, the emergence of novel grain varieties with enhanced enzyme activity and fermentable sugar profiles is helping manufacturers tailor malt extracts to specific product applications.

Another key innovation is the production of enzymatically active gluten-free malt extracts, which are particularly important for gluten-free baking and craft brewing. These extracts enable yeast fermentation, improve dough rise, and contribute to better texture and shelf life in gluten-free baked goods - segments often criticized for inferior sensory quality. In brewing, these extracts help achieve desired coloration, mouthfeel, and flavor complexity in gluten-free beer, a subcategory witnessing robust growth globally. Advances in filtration, deamidation, and proteolytic processing have also improved the removal of residual gluten traces, enabling manufacturers to meet strict international thresholds (e.g., < 20 ppm) for gluten-free certification, enhancing both safety and marketability.

What Sectors Are Driving Adoption of Gluten-Free Malt Extracts and Why?

A broad spectrum of food and beverage sectors is driving the adoption of gluten-free malt extracts, particularly those focused on clean-label innovation, dietary diversification, and inclusive product development. In the bakery and snacks segment, gluten-free malt extracts are widely used to replicate the browning and sweet flavor traditionally derived from barley malt, particularly in cookies, granola bars, and artisanal breads. Manufacturers are leveraging these extracts to enhance taste and visual appeal while ensuring label claims that appeal to gluten-averse and health-conscious consumers.

In craft brewing, gluten-free malt extracts are gaining prominence among microbreweries and home brewers seeking to develop gluten-free beers that retain the depth and richness of traditional ales and lagers. These extracts are helping bridge the quality gap in gluten-free brewing by enabling natural fermentation and balanced flavor profiles. Infant nutrition and sports supplements are also emerging areas, where gluten-free malt extracts provide a source of simple carbohydrates and naturally derived sweeteners, especially in hypoallergenic and sensitive-formulation products. Even confectionery and dairy-based desserts are integrating these extracts to add sweetness and enhance color naturally, as part of the broader clean-label formulation strategy.

What Is Driving Growth Across the Gluten-Free Malt Extracts Market Globally?

The growth in the gluten-free malt extracts market is driven by several factors directly linked to dietary trends, food safety regulations, and product innovation. One of the foremost drivers is the global surge in gluten-free product demand, driven by increasing diagnoses of celiac disease, gluten intolerance, and the popularity of gluten-free diets among health-conscious consumers. Manufacturers are under pressure to formulate products that are not only free from gluten but also nutritionally balanced and sensorially appealing - making gluten-free malt extracts a strategic ingredient in product reformulation.

Rising investment in specialty ingredients and clean-label innovations by food and beverage companies is another key growth driver, particularly in North America and Europe, where consumer expectations for transparency, safety, and dietary inclusivity are highest. Regulatory clarity and the establishment of standardized gluten-free thresholds have also improved consumer trust and product labeling, expanding market access for compliant malt extract products. Furthermore, the growing interest in alternative grains, plant-based foods, and functional nutrition is opening new application opportunities for gluten-free malt extracts beyond traditional categories. Collectively, these trends are establishing gluten-free malt extracts as an essential ingredient in the evolving landscape of allergen-free and health-driven food product development.

Report Scope

The report analyzes the Gluten-Free Malt Extracts market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Form (Powder, Liquid); Application (Food & Beverages, Nutraceuticals, Cosmetic, Other Applications)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Powder segment, which is expected to reach US$8.0 Billion by 2032 with a CAGR of a 5.2%. The Liquid segment is also set to grow at 2.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.4 Billion in 2025, and China, forecasted to grow at an impressive 7.6% CAGR to reach $2.5 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Gluten-Free Malt Extracts Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Gluten-Free Malt Extracts Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Gluten-Free Malt Extracts Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Axiom Foods, Beneo GmbH, Briess Malt & Ingredients Co., Cargill, Incorporated, Cerex S.A. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Gluten-Free Malt Extracts market report include:

  • Axiom Foods
  • Beneo GmbH
  • Briess Malt & Ingredients Co.
  • Cargill, Incorporated
  • Cerex S.A.
  • Döhler GmbH
  • EverGrain Ingredients
  • Grain Processing Corporation
  • Ingredion Incorporated
  • Malt Products Corporation
  • Maltexco S.A.
  • Muntons plc
  • PMV Maltings Pvt. Ltd.
  • Roquette Frères
  • Senson Oy
  • Shafi Gluco Chem Pvt. Ltd.
  • Südzucker AG
  • Tate & Lyle PLC
  • The Scoular Company
  • Viking Malt Oy

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Glycomic Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Glycobiology Research Throw Spotlight on Novel Therapeutic Applications
  • Rising Focus on Personalized Medicine and Biomarker Discovery Drives Demand for Glycan-Based Drugs
  • Integration of Glycomics with Immunotherapy Strengthens Business Case in Oncology and Autoimmune Disorders
  • Expansion of Biopharmaceutical Pipelines Accelerates Investment in Glyco-Engineering Technologies
  • Strategic Collaborations Between Academia and Biotech Fuel Innovation in Glycomics Research
  • Growing Applications in Vaccine Design and Infectious Disease Modulation Generate Market Interest
  • Use of AI in Glycan Mapping Enhances Precision in Drug Development and Disease Profiling
  • Emerging Role of Glycans in Neurological Disorders Expands Targeted R&D Investment
  • Supportive Regulatory Pathways for Rare and Orphan Drugs Accelerate Clinical Trials in Glycomic Therapies
  • Global Genomic and Proteomic Initiatives Drive Integration of Glycomic Data for RWE
  • Scalability Challenges and Complex Manufacturing Present Bottlenecks in Commercialization
  • Licensing and IP Portfolios Create Competitive Advantages for Early Glycomic Innovators
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Glycomic Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Glycomic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Glycomic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Glycomic Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Isolated Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Isolated Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Isolated Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Synthetic Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Synthetic Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Synthetic Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Thrombosis & Chemoprophylaxis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Thrombosis & Chemoprophylaxis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Thrombosis & Chemoprophylaxis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Anemia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Anemia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Anemia Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Cataract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Cataract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Cataract Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Gaucher`s Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Gaucher`s Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Gaucher`s Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for MPS-1 & IV Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for MPS-1 & IV Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for MPS-1 & IV Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Cancer Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Alzheimer`s Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Alzheimer`s Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Alzheimer`s Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Glycoproteins Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Glycoproteins Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Glycoproteins Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Targeting Sialic Acid Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Targeting Sialic Acid Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Targeting Sialic Acid Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Proteoglycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Proteoglycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Proteoglycans Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 44: World Recent Past, Current & Future Analysis for Targeting Glycosaminoglycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 45: World Historic Review for Targeting Glycosaminoglycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: World 13-Year Perspective for Targeting Glycosaminoglycans Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 47: World Recent Past, Current & Future Analysis for Anchored Proteins & Heparin Based Glycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 48: World Historic Review for Anchored Proteins & Heparin Based Glycans Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: World 13-Year Perspective for Anchored Proteins & Heparin Based Glycans Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 50: World Recent Past, Current & Future Analysis for Targeting Glycosphingolipids Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: World Historic Review for Targeting Glycosphingolipids Structure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: World 13-Year Perspective for Targeting Glycosphingolipids Structure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 53: World Recent Past, Current & Future Analysis for Other Structures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 54: World Historic Review for Other Structures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: World 13-Year Perspective for Other Structures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Glycomic Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Axiom Foods
  • Beneo GmbH
  • Briess Malt & Ingredients Co.
  • Cargill, Incorporated
  • Cerex S.A.
  • Döhler GmbH
  • EverGrain Ingredients
  • Grain Processing Corporation
  • Ingredion Incorporated
  • Malt Products Corporation
  • Maltexco S.A.
  • Muntons plc
  • PMV Maltings Pvt. Ltd.
  • Roquette Frères
  • Senson Oy
  • Shafi Gluco Chem Pvt. Ltd.
  • Südzucker AG
  • Tate & Lyle PLC
  • The Scoular Company
  • Viking Malt Oy

Table Information